Peter J. Timoney
Medical Practice in Lexington, KY
License number
Kentucky 42959
Issued Date
Sep 17, 2009
Expiration Date
Feb 28, 2018
Category
Ophthalmology
Type
Faculty
Address
Address
740 S Limestone Street, Ophthalmology, Lexington, KY 40536
Education
Trinity College, University of Dublin, 2002
Phone
(859) 218-2655 (Work)
Personal information
See more information about Peter J. Timoney at radaris.comName
Address
Phone
3417 Nantucket Dr, Lexington, KY 40502
3417 Nantucket Dr, Lexington, KY 40502
Professional information
See more information about Peter J. Timoney at trustoria.com
Peter J Timoney, Lexington KY
Peter J Timoney, Lexington KY
Specialties:
General Surgery
Address:
University Of Kentucky OPH
740 S Limestone St SUITE 301, Lexington 40536
(859) 323-5867 (Phone)
740 S Limestone St SUITE 301, Lexington 40536
(859) 323-5867 (Phone)
Procedures:
Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
Languages:
English
Infectious Cdna Clone Of The Modified Live Virus Vaccine Strain Of Equine Arteritis Virus
Infectious Cdna Clone Of The Modified Live Virus Vaccine Strain Of Equine Arteritis Virus
US Patent:
2010022, Sep 2, 2010
Filed:
May 6, 2009
Appl. No.:
12/436242
Inventors:
Udeni B.R. Balasuriya - Lexington KY, US
Peter J. Timoney - Lexington KY, US
Jianqiang Zhang - Lexington KY, US
Peter J. Timoney - Lexington KY, US
Jianqiang Zhang - Lexington KY, US
International Classification:
C12N 5/10, C07H 21/04, C12N 15/63, C07H 21/02
US Classification:
435352, 536 231, 4353201
Abstract:
An isolated polynucleotide molecule includes a DNA sequence encoding an infectious RNA molecule encoding a modified live viral strain of an Equine arteritis virus, wherein the DNA sequence is SEQ ID NO:1 or a degenerate variant thereof. Also provided are transformed or transfected host cells including that sequence, vectors including the sequence, and isolated infectious RNA molecules encoded by the sequence. Further, a modified DNA sequence encoding an infectious RNA molecule encoding a modified live viral strain of an Equine arteritis virus is provided wherein the DNA sequence is SEQ ID NO:2 or a degenerate variant thereof, including a si lent point mutation allowing distinguishing the modified sequence from the parent and other strains of Equine arteritis virus.